ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: No residual BCR-ABL1-GFP+ cells could be detected in blood, spleen, or BM of DT-treated Foxp3DTR CML mice by FACS 90 days after transplantation (data not shown).